How does Mounjaro monthly payment work in the UK?

What does a monthly Mounjaro payment actually cover?

When you see a monthly price advertised for Mounjaro, the number on the page and what lands in your hand can be two different things. The medicine itself (one pre-filled KwikPen containing four weekly doses of tirzepatide) is one component. But a legal prescription for a prescription-only medicine like Mounjaro also requires a clinical consultation. Some providers charge for that separately. Some add a prescription fee on top. Delivery, especially next-day tracked delivery, is routinely listed as an extra.

It is worth pausing on that for a moment, because the misconception most people carry is that a low headline figure means low total cost. Add a £25 consultation charge, a £10 prescription fee and a £7 delivery charge, and the gap between a provider who looks cheaper and one who is transparent closes quickly. Checking what a monthly payment genuinely covers is the most useful step before comparing any two numbers. Our full breakdown of Mounjaro's monthly cost in the UK walks through exactly that exercise.

The dose also matters in a way that is easy to overlook at the start of treatment. Tirzepatide is licensed in six strengths, beginning at 2.5mg. That first pen exists to let your body adjust, not to drive weight loss. By the time most people reach a therapeutic maintenance dose, the monthly figure is higher than the one they first saw, and our guide to tirzepatide monthly cost explains how that progression affects what you can expect to pay at each stage. Any honest pricing guide should name that clearly.

Has the monthly price of Mounjaro changed recently?

Yes, meaningfully. Eli Lilly revised its UK list price upward from 1 September 2025. Before that date, the highest-dose pen carried a list price of around £122; after it, around £330, as widely reported in August 2025. Private providers absorbed some of that increase and passed on the rest, which is why the market price of Mounjaro looks very different now to articles written before the summer of 2025.

The practical result is that anyone comparing prices across a handful of pharmacy sites today will see a wider range than before, with some providers still adjusting and others already reflecting the new cost base. NICE recommended tirzepatide for adults managing their weight under TA1026, but NHS availability remains in a phased rollout with strict criteria, so the majority of people currently paying a monthly amount are doing so privately. That context is worth holding alongside any number you see quoted.

If you are exploring whether paying for Mounjaro monthly makes sense for your situation, the dose trajectory is the key variable. Starting costs are lower; maintenance costs are higher. A good provider will show you both upfront.

Why is nume not the cheapest option, and why does that matter?

At nume, one transparent price covers the consultation, the prescription, the treatment and free next-working-day tracked delivery by DPD, plus priority aftercare seven days a week and a clinical review before every repeat. There is no subscription, no auto-renewal and no hidden fee waiting at checkout. Every repeat order is individually assessed, your prescriber looks at your progress before approving the next supply, which is both a safety requirement and the kind of oversight that makes a clinical service different from a fulfilment operation.

We are not the cheapest provider listed in a comparison search. That is a deliberate position. The costs we don't cut are clinical review time, dispensing standards and aftercare access. You can see the people behind the service on our clinical team page. The single price we charge reflects what responsible, clinician-led weight management actually costs to run safely.

If you want to understand how our pricing compares to the broader private market, this page sets out the context honestly, including what lower prices usually mean in practice.

Is monthly cost the right question to ask about a prescription medicine?

Price is a reasonable starting point, treatment has to be affordable to be sustainable. But for a prescription-only medicine dispensed via a regulated UK pharmacy, cost is not the only measure that protects you. The MHRA has warned publicly about counterfeit tirzepatide pens, including the discovery of an illegal manufacturing site producing fake Mounjaro pens in the UK in October 2025. Fake pens have contained no active ingredient, wrong concentrations, and in earlier cases involving other weight-loss medicines, insulin. Any seller offering these medicines without requiring a clinical assessment first is operating outside UK law.

The safest check is simple: verify the pharmacy on the GPhC register before handing over payment. nume's GPhC premises registration number is 9012878. A price that looks significantly below the market range for a prescription medicine is a reason to look more carefully, not a reason to act quickly. The clinical outcomes you are trying to achieve depend on genuine medicine, dispensed correctly, with a real prescriber involved. That is what the monthly payment is for.